Xenetic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xenetic and other ETFs, options, and stocks.About XBIO
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen.
CEOJames F. Parslow
CEOJames F. Parslow
Employees2
Employees2
HeadquartersFramingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded2011
Founded2011
Employees2
Employees2
XBIO Key Statistics
Market cap5.74M
Market cap5.74M
Price-Earnings ratio-1.36
Price-Earnings ratio-1.36
Dividend yield—
Dividend yield—
Average volume79.28K
Average volume79.28K
High today$2.80
High today$2.80
Low today$2.47
Low today$2.47
Open price$2.71
Open price$2.71
Volume54.68K
Volume54.68K
52 Week high$13.93
52 Week high$13.93
52 Week low$2.20
52 Week low$2.20
Stock Snapshot
With a market cap of 5.74M, Xenetic(XBIO) trades at $2.52. The stock has a price-to-earnings ratio of -1.36.
On 2025-11-07, Xenetic(XBIO) stock traded between a low of $2.47 and a high of $2.80. Shares are currently priced at $2.52, which is +2.2% above the low and -10.0% below the high.
Xenetic(XBIO) shares are trading with a volume of 54.68K, against a daily average of 79.28K.
During the past year, Xenetic(XBIO) stock moved between $2.20 at its lowest and $13.93 at its peak.
During the past year, Xenetic(XBIO) stock moved between $2.20 at its lowest and $13.93 at its peak.
People also own
Based on the portfolios of people who own XBIO. This list is generated using Robinhood data, and it’s not a recommendation.